[1]
L. Pérez-Ruiz, M. Rodríguez-Mendoza, H. Soto-Molina, Galán-ÁlvarezY., C. Viada-González, and M. Collazo-Herrera, “Nimotuzumab (CIMAher®) in Cuban patients with head and neck cancer stage III/IV: Budget impact analysis”, VM, vol. 29, no. 1, pp. 14-21, Jan. 2020.